TABLE 2. Developed therapeutic agents against RON (Recepteur D'Origine Nantais) in Gastric cancer.
mAb: Monoclonal Antibody, TKI: Tyrosine kinase inhibitor, miR: Micro RNA, VEGFR: Vascular Endothelial Growth Factor Receptors, TIE: Tunica internal endothelial cell kinase, TRKA: Tropomyosin receptor kinase A, HSP: Heatshock protein.